Oramed Pharmaceuticals Inc
ORMP
$4.07-2.63%
End of day · as of Oct 16, 2026, 7:15 PM ET
Mkt cap
$87.22M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$2.00M
EPS (H1 2026)
$2.76
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
2419.75%
Beta
1.62
Div yield
N/A
Sector
Healthcare
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported ORMP revenue for 2025-09-30 was $2.0M. Net income was $48.4M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ORMP currently screens at market cap $87.2M.
Use this ORMP research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full ORMP income, balance, and cash tables.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company in the Healthcare sector.
Latest cached Oramed Pharmaceuticals Inc (ORMP) revenue for Sep 30, 2025 was $2.0M. Net income was $48.4M. Statements: https://lician.com/financials/ormp
Oramed Pharmaceuticals Inc (ORMP) market capitalization is $87.2M on the latest cached snapshot.
Oramed Pharmaceuticals Inc (ORMP) cached previous close $4.18; day range $3.99 – $4.19; volume 277,084. Session quote: https://lician.com/quote/ormp
Oramed Pharmaceuticals Inc (ORMP) latest cached earnings event is "ORMP earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ORMP filing is 8-K · Sep 17, 2026. Filings: https://lician.com/sec/ormp